Johan Nilvebrant

8PUBLICATIONS
38CO-AUTHORS
GlycoconjugatesMedical devicesMedical molecular engineering of nucleic acids and proteinsPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 14, 2024
Site-directed conjugation of single-stranded DNA to affinity proteins: quantifying the importance of conjugation strategy.

Andres Rocha Tapia, Fabrice Abgottspon, Johan Nilvebrant

|Dec 02, 2022
Modular UBE2H-CTLH E2-E3 complexes regulate erythroid maturation.

Dawafuti Sherpa, Judith Mueller, Özge Karayel

|Nov 27, 2021
Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic Platform.

Valentina Palacio-Castañeda, Rik Oude Egberink, Arbaaz Sait

|Nov 24, 2021
The Wittig bioconjugation of maleimide derived, water soluble phosphonium ylides to aldehyde-tagged proteins.

Rafael W Hartmann, Matthijs Pijnappel, Johan Nilvebrant

|Oct 13, 2021
Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.

Jakob Lindberg, Johan Nilvebrant, Per-Åke Nygren

|Feb 28, 2019
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.

Ida Hafstrand, Ece Canan Sayitoglu, Anca Apavaloaei

Pageof 2